79337468 - PLEXPLUS

Information

• Trademark
• 79337468

• Source

• Serial Number

  79337468

• Registration Number

  7057884

• International Classifications

  • 1 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry
  • 5 - Pharmaceutical and veterinary preparations
  • 10 - Surgical, medical, dental and veterinary apparatus and instruments, artificial limbs, eyes and teeth
  • 42 - Scientific and technological services and research and design relating thereto
  • 44 - Medical services

• Filing Date

  September 27, 2021
  3 years ago

• Registration Date

  May 23, 2023
  a year ago

• Transaction Date

  September 17, 2023
  a year ago

• Status Date

  May 23, 2023
  a year ago

• Published for Opposition Date

  March 07, 2023
  a year ago

• Location Date

  May 23, 2023
  a year ago

• Status Code

  700

• Current Location

  PUBLICATION AND ISSUE SECTION

  Employee Name

  HESIK, APRIL ANNE

• Attorney Docket Number

  T-4921 US MP

  Attorney Name

  Joi A. White

  Law Office Assigned Location Code

  N60

• Owners

  • SpeeDx Pty Ltd

Case File Statements

• GS0051: Pharmaceutical and veterinary preparations and substances consisting of catalytic DNA molecules and associated detection reagents for the diagnosis of diseases, for detection and identification of pathogens, for the detection of antibiotic resistance, for the analysis of gene expression, protein expression, metabolite expression, inflammation, and immune-suppression and immune disorders, for genotyping, analysis of polymorphisms, detection of acquired or inherited genetic mutations, detection and analysis of epigenetic alterations, and for analysis of response to therapy; reagents for medical and veterinary use; nucleic acid amplification reagents for medical use; nucleic acid sequencing preparations for medical use; chemical preparations containing enzymes for medical purposes for the diagnosis of diseases or detection or identification of pathogens, for the detection of antibiotic resistance, for the analysis of gene expression, protein expression, metabolic expression, inflammation, and immune-suppression and immune disorders for genotyping, analysis of polymorphisms, detection of acquired or inherited genetic mutations, detection and analysis of epigenetic alterations, analysis of response to therapy; chemical preparations containing enzymes for pharmaceutical, veterinary and medical purposes for the diagnosis of diseases or detection or identification of pathogens, for the detection of antibiotic resistance, for the analysis of gene expression, protein expression, metabolic expression, inflammation, and immune-suppression and immune disorders for genotyping, analysis of polymorphisms, detection of acquired or inherited genetic mutations, detection and analysis of epigenetic alterations, analysis of response to therapy; enzymes for pharmaceutical, veterinary and medical purposes for the diagnosis of diseases or detection or identification of pathogens, for the detection of antibiotic resistance, for the analysis of gene expression, protein expression, metabolic expression, inflammation, and immune-suppression and immune disorders for genotyping, analysis of polymorphisms, detection of acquired or inherited genetic mutations, detection and analysis of epigenetic alterations, analysis of response to therapy; medical kits containing medical and/or pharmaceutical preparations and associated detection reagents for the diagnosis of diseases, for detection and identification of pathogens, for the detection of antibiotic resistance, for the analysis of gene expression, protein expression, metabolite expression, inflammation, and immune-suppression and immune disorders, for genotyping, analysis of polymorphisms, detection of acquired or inherited genetic mutations, detection and analysis of epigenetic alterations, and for analysis of response to therapy; clinical diagnostic preparations for medical or veterinary use; biological chemical diagnostic test kits comprised of reagents and assays for medical laboratory use in analysis that test for the presence of gene expression, protein expression, metabolite expression, inflammation, immune-suppression, immune disorders
• PM0001: PLEX PLUS
• GS0011: Chemicals used in industry and science; chemical preparations for use in photography; chemicals for use in agriculture, horticulture and forestry except fungicides, herbicides, insecticides and parasiticides; reagents and reactants in this class for scientific and research use, medical research use, and nonmedical use; enzymes for industrial or scientific purposes; nucleic acid for other than medical and veterinary purposes; nucleic recombinant acid for other than medical and veterinary purposes; acids namely inorganic acids for industrial purposes; DNA polymerase; chemicals used in food processing and screening; chemicals used in environmental monitoring
• GS0441: Medical services; human healthcare services; medical testing services relating to the diagnosis and treatment of disease; genetic testing for medical purposes; medical and health services relating to dna, genetics and genetic testing; medical diagnostic services in the nature of medical testing and medical analysis; providing collected and analysed medical information in the field of genetic and treatment information for diseases and disorders for diagnostic and treatment purposes; medical diagnostic imaging and molecular medicine; molecular medical diagnostics testing
• GS0101: Surgical apparatus and instruments; medical and veterinary apparatus and instruments being diagnostic testing apparatus and instruments for the detection of antibiotic resistance, for the analysis of gene expression, protein expression, metabolic expression, inflammation, and immune-suppression and immune disorders for genotyping, analysis of polymorphisms, detection of acquired or inherited genetic mutations, detection and analysis of epigenetic alterations, analysis of response to therapy; diagnostic testing apparatus and instruments for medical purposes; diagnostic testing kits consisting primarily of diagnostic testing apparatus and instruments for the purpose of detecting antibiotic resistance, for the analysis of gene expression, protein expression, metabolic expression, inflammation, and immune-suppression and immune disorders for genotyping, analysis of polymorphisms, detection of acquired or inherited genetic mutations, detection and analysis of epigenetic alterations, analysis of response to therapy; point of care medical devices being diagnostic testing apparatus for the purpose of detecting antibiotic resistance, for the analysis of gene expression, protein expression, metabolic expression, inflammation, and immune-suppression and immune disorders for genotyping, analysis of polymorphisms, detection of acquired or inherited genetic mutations, detection and analysis of epigenetic alterations, analysis of response to therapy; medical screening kits comprised of medical screening and testing apparatus for the diagnosis of disease, detection and identification of pathogens, for the detection of antibiotic resistance, for the analysis of gene expression, protein expression, metabolic expression, inflammation, and immune-suppression and immune disorders for genotyping, analysis of polymorphisms, detection of acquired and inherited genetic mutations, detection and analysis of epigenetic alterations, analysis of response to therapy; biological chemical test kits for medical laboratory use in analysis of gene expression, protein expression, metabolite expression, inflammation, immune-suppression, immune disorders
• GS0421: Scientific and technological services and research and design relating thereto, namely, DNA analysis services for scientific research purposes, scientific research consulting in the field of genetics; scientific research in the field of genetics; genetic engineering services for scientific purposes; scientific research in the field of genetics and genetic engineering; scientific research relating to genetics; chemistry services; research relating to chemistry; scientific research relating to chemistry; research in the field of chemistry; laboratory analysis in the field of chemistry; development of medical diagnostic apparatus; design of medical diagnostic apparatus; research relating to molecular sciences; analysis of data generated by scientific and medical experiments and tests; biological, bacteriological, chemical, biochemical, dna, rna, protein, polynucleic acid and molecular analysis and evaluation services; dna and rna and polynucleic acid and protein sequencing, analysis and evaluation services; genome sequencing services and the analysis and evaluation of data resulting therefrom; provision of reports relating to scientific and medical experiments, the results of scientific and medical experiments and tests, the analysis and evaluation of scientific and medical data, and data generated by scientific and medical experiments and tests; scientific and medical research and development services in the field of the diagnosis of disease, detection and identification of pathogens, for the detection of antibiotic resistance, for the analysis of gene expression, protein expression, metabolic expression, inflammation, and immune-suppression and immune disorders for genotyping, analysis of polymorphisms, detection of acquired or inherited genetic mutations, detection and analysis of epigenetic alterations, analysis of response to therapy; custom design and development of biochemical assays

Case File Event Statements

• 9/17/2023 - a year ago

  38 - FINAL DECISION TRANSACTION PROCESSED BY IB Type: FINO

• 8/28/2023 - a year ago

  37 - FINAL DISPOSITION NOTICE SENT TO IB Type: FICS

• 8/28/2023 - a year ago

  36 - FINAL DISPOSITION PROCESSED Type: FIMP

• 8/23/2023 - a year ago

  35 - FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB Type: FICR

• 5/23/2023 - a year ago

  34 - NOTICE OF REGISTRATION CONFIRMATION EMAILED Type: NRCC

• 5/23/2023 - a year ago

  33 - REGISTERED-PRINCIPAL REGISTER Type: R.PR

• 3/7/2023 - a year ago

  32 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB

• 3/7/2023 - a year ago

  31 - PUBLISHED FOR OPPOSITION Type: PUBO

• 3/6/2023 - a year ago

  30 - NOTIFICATION PROCESSED BY IB Type: GPNX

• 2/15/2023 - a year ago

  29 - NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB Type: OPNS

• 2/15/2023 - a year ago

  28 - NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB Type: OP2R

• 2/15/2023 - a year ago

  27 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP

• 1/27/2023 - a year ago

  26 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA

• 1/27/2023 - a year ago

  25 - EXAMINER'S AMENDMENT ENTERED Type: XAEC

• 1/27/2023 - a year ago

  24 - NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Type: GNEN

• 1/27/2023 - a year ago

  23 - EXAMINERS AMENDMENT E-MAILED Type: GNEA

• 1/27/2023 - a year ago

  22 - EXAMINERS AMENDMENT -WRITTEN Type: CNEA

• 1/19/2023 - a year ago

  21 - PREVIOUS ALLOWANCE COUNT WITHDRAWN Type: ZZZX

• 1/17/2023 - a year ago

  20 - WITHDRAWN FROM PUB - OG REVIEW QUERY Type: PBCR

• 12/30/2022 - a year ago

  19 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA

• 12/29/2022 - a year ago

  18 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME

• 12/28/2022 - a year ago

  17 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA

• 12/28/2022 - a year ago

  16 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA

• 12/12/2022 - 2 years ago

  15 - APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Type: CHAN

• 12/12/2022 - 2 years ago

  14 - TEAS CHANGE OF CORRESPONDENCE RECEIVED Type: TCCA

• 12/12/2022 - 2 years ago

  13 - TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS Type: ECDR

• 12/12/2022 - 2 years ago

  12 - ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Type: ARAA

• 12/12/2022 - 2 years ago

  11 - TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Type: REAP

• 12/12/2022 - 2 years ago

  10 - TEAS CHANGE OF OWNER ADDRESS RECEIVED Type: COAR

• 7/20/2022 - 2 years ago

  9 - REFUSAL PROCESSED BY IB Type: RFNT

• 6/29/2022 - 2 years ago

  8 - NON-FINAL ACTION MAILED - REFUSAL SENT TO IB Type: RFCS

• 6/29/2022 - 2 years ago

  7 - REFUSAL PROCESSED BY MPU Type: RFRR

• 6/29/2022 - 2 years ago

  6 - NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW Type: RFCR

• 6/28/2022 - 2 years ago

  5 - NON-FINAL ACTION WRITTEN Type: CNRT

• 6/28/2022 - 2 years ago

  4 - ASSIGNED TO EXAMINER Type: DOCK

• 4/12/2022 - 2 years ago

  3 - APPLICATION FILING RECEIPT MAILED Type: MAFR

• 4/8/2022 - 2 years ago

  2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS

• 4/7/2022 - 2 years ago

  1 - SN ASSIGNED FOR SECT 66A APPL FROM IB Type: REPR